The Icahn School of Medicine at Mount Sinai has launched a blockchain lab for biomedical research. The research lab will use Blockchain Technology in order to solve various issues in healthcare and medical science.
What is the main purpose of establishing Blockchain Lab?
The lab is referred to as the Center of Biomedical Blockchain Research (CBBR). The center’s research will set the foundation for its upcoming industry partnership program for companies which are looking to build biomedical blockchain solutions that address problems in clinical medicine and biomedical research. The center’s main aim is to build healthcare blockchain applications by:
- Conducting academic evaluations of blockchain-enabled solutions
- Providing partnerships and conducting services with companies which are working on these projects
- Developing as well as testing blockchain-enabled systems within the Mount Sinai Health System
The Center of Biomedical Blockchain Research will be handled by Joel Dudley, Ph.D., Executive Vice President of Precision Health at Mount Sinai along with Noah Zimmerman, Ph.D., Assistant Professor of Genetics and Genomic Sciences and Director of the Health Data and Design Innovation Center.
Dr. Joel Dudley accepted the broken network of regional as well as global healthcare systems. He is a medical professional, who will be doing research on Blockchain to improvise data analytics and machine learning. He especially stated that conventional systems don’t possess any tool to easily access healthcare information. Dr. Dudley also believes that Blockchain will help to solve various health care issues.
Dr. Dudley’s research is centered on the application of data-driven approaches and machine intelligence to resolve issues in biology and healthcare. The new research lab praises his earlier work of building predictive health apps from electronic health records, wearables, and other digital health information.
Dr. Noah Zimmerman possesses great experience in biomedical data, machine learning, and data governance. He hopes that the new blockchain research will improve healthcare delivery and also reduce medical costs.
Various companies around the world are exploring the use of Blockchain in biology and healthcare sector. Some of the popular applications include improving quality control in the pharma industry to reduce fake drugs, developing new tools to access medical information easily, etc.
Dr. Dudley said, “We expect that some early use cases could emerge from areas where existing systems and approaches fall short”. He further added, “The fragmented nature of regional as well as global healthcare systems prevents the flow of vital information and creates barriers to access for underserved groups. We see the potential for blockchain and related technologies to enable applications that support more unified healthcare ecosystems and serve the greater goals of realizing national and global precision health networks.”